[Form 4] Bruker Corporation Insider Trading Activity

Rhea-AI Filing Summary

Busse Falko, identified as President, Biospin Group and a director/officer of Bruker Corporation (BRKR), reported equity awards granted on 08/15/2025. The filing shows 9,282 restricted stock units (RSUs) were acquired at no cash price and 8,774 stock options were granted with a $33.52 exercise price. The RSUs vest in equal installments on the first four anniversaries of the original grant date and the options vest on the same four-year schedule; the options are exercisable beginning 08/15/2026 and expire 08/15/2035. Following the reported transactions, the reporting person beneficially owns 48,171 shares of common stock and 8,774 shares underlying options. The form was signed by an attorney-in-fact on 08/19/2025.

Positive

• 9,282 RSUs granted to the reporting person on 08/15/2025
• 8,774 stock options granted with a $33.52 exercise price and 08/15/2035 expiration
• Vesting for both RSUs and options occurs in equal installments over four years

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine executive equity grants disclosed; vesting schedule spans four years, tying compensation to multi-year tenure.

The Form 4 documents standard equity compensation for a senior officer: a grant of 9,282 RSUs and 8,774 stock options with a $33.52 strike. Vesting occurs in equal annual installments over four years and options become exercisable starting one year after grant, with a ten-year contractual term to expiration. This disclosure is material for ownership and potential dilution tracking but does not indicate any sale or disposition of existing shares. Impact is informational for governance and insider alignment with long-term incentives.

Compensation Analyst

TL;DR: Grants combine time-based RSUs and options; exercise price and vesting timeline are specified, typical of long-term incentive awards.

The filing specifies the mix and scale of long-term incentives: 9,282 RSUs (no cash price) and 8,774 options at $33.52. Vesting in four equal annual tranches aligns payout with continued service. The options' exercisability beginning 08/15/2026 and expiration in 2035 set a long runway for potential upside. No cash purchases or dispositions were reported. For compensation benchmarking, the details allow calculation of potential future dilution and time-weighted vesting expense recognition, but the form contains no dollar valuations beyond the strike price.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Busse Falko

(Last) (First) (Middle)

40 MANNING ROAD

(Street)

BILLERICA MA 01821

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BRUKER CORP [ BRKR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT, BIOSPIN GROUP

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		A		9,282(1)	A	$0	48,171	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Purchase)	$33.52	08/15/2025		A		8,774		08/15/2026(2)	08/15/2035	Common Stock	8,774	$0	8,774	D

Explanation of Responses:

1. The Restricted Stock Units granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

2. The Stock Options granted to the Reporting Person on August 15, 2025 (the "Original Grant Date") vest in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.

	/s/ Michael Simone, Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.